Sedation Level on Machine Learning With Electroencephalogram in Painless Gastroenteroscopy Patients
NCT ID: NCT05545397
Last Updated: 2022-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2022-09-15
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Application of Portable Ultrasonic Evaluation of Gastric Contents in Painless Gastroscopy
NCT05469633
Propofol Versus Midazolam With Fentanyl for EGD Endomicroscopy
NCT01053871
Deep Learning Algorithm for the Diagnosis of Gastrointestinal Diseases
NCT04222439
Changes in Etomidate Dosage in Insomnia Patients Undergoing Digestive Endoscopy
NCT07028177
Non-invasive Measurement of Gastric Motility
NCT04992884
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The propofol group
Patients undergoing painless gastroenteroscopy under general anesthesia
Propofol
And pump propofol at a rate of 600ml/h. The degree of sedation was assessed by the MOAA/S scale until the depth sadation of the patient during the monitor of EEG
EEG montior
And pump propofol at a rate of 600ml/h. The degree of sedation was assessed by the MOAA/S scale until the depth sadation of the patient during the monitor of EEG
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Propofol
And pump propofol at a rate of 600ml/h. The degree of sedation was assessed by the MOAA/S scale until the depth sadation of the patient during the monitor of EEG
EEG montior
And pump propofol at a rate of 600ml/h. The degree of sedation was assessed by the MOAA/S scale until the depth sadation of the patient during the monitor of EEG
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. ASA classification is Ⅰ-Ⅱ
3. Patients who are willing to cooperate
4. No schizophrenia,epilepsy and other neurological diseases
Exclusion Criteria
2. Patients who are unwilling to cooperate
3. Patients with psychiatric disorders
4. Patients using sedative drugs for a long time
5. Patients with neuropsychiatric disorders
6. Patients with severe heart, liver, kidney and respiratory diseases
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
General Hospital of Ningxia Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ningxia Medical University Cardiovascular and Cerebrovascular Disease Hospital
Yinchuan, The Ningxia Hui Autonomous Region, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ma Hanxiang
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Huiwen Zhang
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.